Increase In Extended-Release Buprenorphine Indicates Increasing Access, Acceptability Among People With OUD In Massachusetts 

After extended-release buprenorphine became available for treating opioid use disorder (OUD) in Massachusetts in 2018, the number of people receiving it increased from 135 in 2018 to to 4,742 in 2023, according to a recent study. During those same years, the number of people receiving non–extended-release buprenorphine decreased from 54,956 to 51,768. The researchers concluded that there is increasing access and acceptability of extended-release formulations of buprenorphine among people with OUD in the state. To reduce opioid overdose deaths and other consequences of OUD, further research on improving access and acceptability of all . . .